§ EQUITY
USD

APYX

APYX MEDICAL CORP
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
36 increased/new, 25 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Nantahala Capital Management, LLC3.4M0.5%−13%
Archon Capital Management LLC2.8M5.8%−13%
ROYCE & ASSOCIATES LP2.6M0.1%+7%
VANGUARD CAPITAL MANAGEMENT LLC1.6Mn/an/a
AIGH Capital Management LLC1.1M0.6%±0%
Silverberg Bernstein Capital Management LLC1.0M2.1%+1%
◇ AC INTELLIGENCE

Top institutional owners for APYX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER89.6% · 49 holders
PASSIVE / INDEX4.1% · 2 holders
DEALER / BANK2.7% · 9 holders
TACTICAL / MACRO1.9% · 3 holders
SYSTEMATIC / QUANT1.6% · 3 holders
QUALITY / COMPOUNDER0.1% · 2 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for APYX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention APYX yet.